Product Program year 2023 Source: CMS Open Payments

FiberLase CO2 Fiber

Device FiberLase CO2 Fiber_URO

PDI 07290109142012

Open in the dashboard

General payments

$354

4 payments

Research payments

$0

0 payments

Through program year 2023, $354 in general payments and $0 in research payments were reported against FiberLase CO2 Fiber (FiberLase CO2 Fiber_URO).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2023 General $354 4

Breakdown

Who paid General payments · program year 2023
  1. Boston Scientific Corporation $354 4 payments
Top recipients General payments · program year 2023
  1. Harishanker Jeyarajan Plastic Surgery within the Head & Neck · Birmingham, AL $149 42% · 1 payment
  2. Bharat Panuganti Otolaryngology · Saint Louis, MO $149 42% · 1 payment
  3. Mark Sakai Otolaryngology · Hilo, HI $29 8% · 1 payment
  4. Melissa Guanche Sports Medicine · Miami, FL $28 8% · 1 payment

Each share is of general payments naming this product in 2023.

Specialties paid General payments · program year 2023
  1. Otolaryngology $178 50% · 2 practitioners
  2. Plastic Surgery within the Head & Neck Otolaryngology $149 42% · 1 practitioner
  3. Sports Medicine Physical Medicine & Rehabilitation $28 8% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2023
  1. Alabama $297 84% · 2 recipients
  2. Hawaii $29 8% · 1 recipient
  3. Florida $28 8% · 1 recipient

Each share is of general payments naming this product in 2023 where a state was reported.

4 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record